FCE News https://fcenews.it/index.php?option=com_content&view=category&id=1016&layout=blog&Itemid=138 Sat, 18 Mar 2017 18:24:38 +0000 Joomla! 1.5 - Open Source Content Management it-it Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor https://fcenews.it/index.php?option=com_content&view=article&id=215775:does-risk-lymphoma-patients&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215775:does-risk-lymphoma-patients&catid=1016:reumatologia&Itemid=138

We read with interest the paper by Mercer et al1 focusing on the risk of lymphoma in patients included in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BS ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor by Nocturne et al https://fcenews.it/index.php?option=com_content&view=article&id=215776:response-does-risk-lymphoma&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215776:response-does-risk-lymphoma&catid=1016:reumatologia&Itemid=138

We thank Nocturne et al1 for their interest and comments on our recent paper, which looked at lymphoma risk over the medium term in a cohort of patients receiving tumour necrosis factor inhi ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

What is rheumatoid arthritis Considering consequences of changed classification criteria https://fcenews.it/index.php?option=com_content&view=article&id=215777:what-rheumatoid-arthritis-considering&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215777:what-rheumatoid-arthritis-considering&catid=1016:reumatologia&Itemid=138 Changes in classification criteria

Rheumatoid arthritis (RA) was recognised as a separate disease entity in the middle of the 20th century. Since then several sets of classification criteria were developed for use in clini ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

EULAR revised recommendations for the management of fibromyalgia https://fcenews.it/index.php?option=com_content&view=article&id=215778:eular-revised-recommendations-management&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215778:eular-revised-recommendations-management&catid=1016:reumatologia&Itemid=138 Objective

The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ‘expert opinion’.

[email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000 Consensus-based recommendations for the management of juvenile dermatomyositis https://fcenews.it/index.php?option=com_content&view=article&id=215779:consensus-based-recommendations-management&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215779:consensus-based-recommendations-management&catid=1016:reumatologia&Itemid=138 Background

In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EU https://fcenews.it/index.php?option=com_content&view=article&id=215780:patients-with-seronegative-have&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215780:patients-with-seronegative-have&catid=1016:reumatologia&Itemid=138 Objectives

To compare the presentation of seropositive and seronegative early rheumatoid arthritis (RA) in disease-modifying antirheumatic drug (DMARD)-naïve patients classified according to the 2010 American College of Rheu ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study https://fcenews.it/index.php?option=com_content&view=article&id=215781:efficacy-safety-switching-from&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215781:efficacy-safety-switching-from&catid=1016:reumatologia&Itemid=138 Objectives

To investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS).

Methods... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000 Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA exte https://fcenews.it/index.php?option=com_content&view=article&id=215782:efficacy-safety-biosimilar-infliximab&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215782:efficacy-safety-biosimilar-infliximab&catid=1016:reumatologia&Itemid=138 Objectives

To assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing CT-P13 in patients with rheumatoid arthritis (RA) for an addi ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis https://fcenews.it/index.php?option=com_content&view=article&id=215783:ankylosing-spondylitis-risk-factor&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215783:ankylosing-spondylitis-risk-factor&catid=1016:reumatologia&Itemid=138 Aims

To assess and compare the incidence of cardiovascular (CV) events, by CV phenotype, between patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA) and the general population.

Methods

Us ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000

Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis https://fcenews.it/index.php?option=com_content&view=article&id=215784:disease-activity-associated-with&catid=1016:reumatologia&Itemid=138 https://fcenews.it/index.php?option=com_content&view=article&id=215784:disease-activity-associated-with&catid=1016:reumatologia&Itemid=138 Objectives

Disease activity has emerged as a new, independent risk factor for cardiovascular disease in patients with rheumatoid arthritis (RA). We tested if disease activity in RA was associated with lower left ventricular (LV) sys ... ...]]> [email protected] (Annals of the Rheumatic Diseases current issue ) Reumatologia Wed, 01 Feb 2017 08:00:00 +0000